GLP1 Europe › Legality › the Netherlands
Is retatrutide legal in the Netherlands?
Short answer
The Netherlands has the strictest law of the four countries we cover. Its medicines act prohibits not only selling and importing an unauthorised medicine but also holding one in stock, and its exceptions are professional ones: there is no personal-use carve-out.
Violations are economic offences carrying up to six years' imprisonment when intentional. Whether the stock-holding prohibition would actually be applied to a private user's own supply has not been tested in any case we could find, and we say so rather than guessing.
Read this first
This page describes published law and documented enforcement, on the date shown above. It is not legal advice, it can lag changes, and how the law applies to a specific person is a question for a lawyer in this country. Retatrutide itself has no marketing authorisation anywhere in the world, so everything here concerns an unauthorised medicine.
What the law says
Article 40 of the Geneesmiddelenwet, the Dutch medicines act, prohibits placing a medicine on the market without an authorisation, and then goes further than its neighbours: it is prohibited to hold in stock, offer for sale, sell, supply, dispense, import or export a medicine for which no authorisation exists. The listed exceptions cover pharmacists, physicians, regulatory situations and the like. None of them is a personal-use exception.
These prohibitions are enforced through the economic offences act: intentional violation is an indictable offence carrying up to six years' imprisonment or a substantial fine, unintentional violation up to a year.
Possession, stated carefully
On its face, the prohibition on holding an unauthorised medicine in stock reaches further than German, French or Spanish law, which do not penalise mere possession. Whether Dutch courts would read "holding in stock" to cover a private person's own-use supply is not settled by any authority we could locate, and no prosecution of a private user is documented. The accurate statement is this: the Dutch prohibition is drafted broadly enough to cover it, the professional exceptions do not obviously help a private buyer, and the question appears untested. Anyone for whom this distinction matters needs Dutch legal advice, not a website.
Importing for personal use
The act's licence requirement for importing does not apply to medicines evidently intended for the personal use of the person transporting them, the traveller case. A postal parcel is not transported by its recipient, and for an unauthorised medicine the article 40 prohibition on bringing it into the country applies with no traveller exception among its clauses. The postal route into the Netherlands has no legal basis.
What enforcement actually looks like
The health inspectorate acts against sellers: site takedowns, administrative fines, and referral of criminal trade to prosecutors. It logged around 200 reports of illegal online medicine offers in 2024, double the year before, with weight-loss medicines an increasingly common category. In June 2026 the inspectorate warned that hundreds of thousands of people in the Netherlands use these medicines and roughly a third of injectable users obtain them illegally.
The health consequences are being counted. The national poisons centre recorded 149 poisoning reports involving injectable weight-loss medication in 2025, up from 76 in 2024, and for retatrutide specifically, 6 reports in 2025 and already 12 in the first five months of 2026, noting that the substance is not registered as a medicine in the Netherlands. In July 2026 two patients ended up in comas after online "semaglutide" turned out to contain insulin.
Does a "research use only" label change anything?
No. The Dutch definition of a medicine carries the same presentation and function limbs as EU law: a substance presented as suitable for treating disease, or administered to modify physiological functions through pharmacological or metabolic action, is a medicine. An injectable peptide with GLP-1 activity is inside that definition whatever its label says. The label's legal position in full.
Common questions
- Is possession actually prosecuted in the Netherlands?
We found no documented prosecution of a private user for own-use possession. The law is drafted broadly enough to allow one, which is exactly why we describe the Dutch position as the strictest and the least tested of the four.
- How is this different from Germany?
Germany's act penalises importing and supplying but not having. The Dutch act adds holding in stock to the prohibited list and provides no personal-use exception, so the gap a German buyer sits in does not clearly exist in Dutch law.
- What are the health numbers behind the warnings?
Poisoning reports for injectable weight-loss medicines nearly doubled in a year, retatrutide reports doubled again in five months of 2026, and the inspectorate estimates a third of injectable users source illegally. Those are the regulator's and poison centre's own figures.
Sources
- Geneesmiddelenwet, articles 1, 18 and 40, consolidated text at wetten.overheid.nl, checked 14 August 2026.
- Wet op de economische delicten, articles 1 and 6.
- IGJ, reporting on illegal online medicine offers, 2024 to 2026, and warning of 24 June 2026.
- NVIC, national poisons information centre, figures on weight-loss injection poisonings including retatrutide, June 2026.
- Pharmaceutisch Weekblad, two patients in coma after falsified semaglutide, July 2026.
- CBG, guidance on buying weight-loss medicines online.
Not legal advice. Laws and enforcement practice change, and individual circumstances differ. For a decision that affects you, consult a lawyer qualified in the Netherlands.